Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Sensydia Corporation logo — Advancing cardiovascular care with non-invasive, point-of-ca...

Sensydia Corporation

Advancing cardiovascular care with non-invasive, point-of-care hemodynamic measurement.

Founded 2015 United States Los Angeles, United States 7 employees Grant Total: $20.80M AI, Hardware +3

General Information

Company Name Sensydia Corporation
Founded Year 2015
Location United States Los Angeles, United States
Employees 7
Industries AI, Hardware, Health Care +2
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Sensydia Corporation. To contact Sensydia Corporation, visit sensydia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sensydia Corporation compare?

A PDF of Sensydia Corporation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sensydia Corporation soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sensydia Corporation

Sensydia, founded in 2015, aims to revolutionize cardiovascular care with its non-invasive, point-of-care hemodynamic measurement platform. The company's flagship product, the Sensydia Cardiac Performance System™ (CPS), leverages proprietary sensor technology and machine learning to provide critical insights for heart failure, sepsis, pulmonary hypertension, and other critical diseases. This entirely non-invasive system, trained to the gold standard, can be deployed within minutes in various settings, from hospitals to homes. By democratizing hemodynamic insights, CPS has the potential to enable early disease detection and improve disease management. In June 2023, Sensydia secured a significant $3.00M grant investment from the National Heart, Lung and Blood Institute, underscoring the confidence of a reputable institutional investor in the company's innovative approach. With its focus on AI, hardware, healthcare, IT, and medical devices, Sensydia, headquartered in the United States, represents a promising player in the intersection of technology and healthcare.

Business keywords: cardiovascular care, hemodynamic measurement, point-of-care technology, portable medical devices, non-invasive monitoring, sensor technology, critical patient management, heart failure, sepsis, pulmonary hypertension, early disease detection, disease management, medical innovation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $3.00M 1
National Heart, Lung and Blood Institute
National Heart, Lung and Blood Institute
05 Jun 2023
Venture Round $8.00M 3
Colle Capital Frontier Venture Capital Orlando Health Ventures
Colle Capital, Frontier Venture Capital +1
09 May 2023
Series C $4.12M -
18 Aug 2020
Series B $3.73M 1
Colle Capital
Colle Capital
02 Aug 2017
Series A $1.95M 1
Colle Capital
Colle Capital
01 Mar 2016

Sensydia Corporation Alternatives & Competitors

View All Alternatives
Sensydia Corporation vs
Finapres Medical Systems
Finapres Medical Systems The Netherlands

The leading technology for continuous non-invasive blood pressure measurement, autonomic testing and...

16 employees
Health Care, Medical Devices
Sensydia Corporation vs
Cardiospire
Cardiospire United States

Non-invasive hemodynamic monitoring

Convertible Note
4 employees
Health Care, Medical Devices
Sensydia Corporation vs
CorVista® Health
CorVista® Health Canada

Shortening the path from symptoms to diagnosis

Series C
27 employees
AI, Analytics
Compare Sensydia Corporation vs CorVista® Health
View all alternatives

FAQ About Sensydia Corporation

Advancing cardiovascular care with non-invasive, point-of-care hemodynamic measurement.
Sensydia Corporation was founded in 2015.
Sensydia Corporation is headquartered in Los Angeles, United States.
Sensydia Corporation operates in AI, Hardware, Health Care, IT and Medical Devices. Its work centres on cardiovascular care, hemodynamic measurement, point-of-care technology and portable medical devices.
Sensydia Corporation has approximately 7 employees.
Sensydia Corporation has completed 5 funding rounds, raising a total of $20.80M. The latest funding stage is Grant.
Top alternatives and competitors to Sensydia Corporation include Finapres Medical Systems, Cardiospire, CorVista® Health, Vixiar Medical, Spirometrix, Inc. (now Spirosure, Inc.). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sensydia Corporation and Finapres Medical Systems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sensydia Corporation, https://bouncewatch.com/company/sensydia, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes